424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | EFFECT: Others
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | EFFECT: Others
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | EFFECT: Others
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 424B3: Prospectus
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | EFFECT: Others
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | F-4/A: Registration statement for securities issued by foreign private issuers in certain business combination transactions (Amendment)
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | F-4/A: Registration statement for securities issued by foreign private issuers in certain business combination transactions (Amendment)
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 8-A12B: Registration of a class of securities on a national securities exchange
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | F-4/A: Registration statement for securities issued by foreign private issuers in certain business combination transactions (Amendment)